MediWales are holding their annual BioWales in London conference on the 12th of March 2025.
This conference will bring together industry and health to showcase Welsh innovation in life sciences, including MedTech, diagnostics and NHS collaborations. Delegates will have the chance to discuss the latest breakthroughs and advancements in these fields while exploring new opportunities for growth and collaboration.
Parameters are generally used in patent claims to define subject matter which cannot be expressed in terms of structural features. They can be the most appropriate way to ensure that a claim scope effectively covers an inventor’s contribution. The use of parameters is common for inventions in the chemical field but they can find applicability in a wide variety of technological areas.
12th February 2025 – Cambridge, UK – Cresset, a leading provider of integrated in silico solutions for small molecule drug discovery announces the release of its Flare platform V10, bringing enhanced scientific features for both computational and medical chemists.
The latest release includes significantly enhanced Free Energy Perturbation (FEP) calculations with the inclusion of Absolute FEP, Protein-protein docking, and Protein-Ligand Interaction Fingerprints (PLIF).
Science, research and innovation are core disciplines that will undoubtedly help the human race address many of the key challenges it faces. Whether it is dealing with climate change, ending world hunger or living healthier and longer lives, we need to create environments that will enable scientists and researchers to make ground-breaking discoveries to be made. That means building a support network to work alongside them made up of individuals with other skills and disciplines.
PrecisionLife has been awarded a €2.5m non-dilutive grant by the European Innovation Council (EIC) for its TRANSCEND project, to more rapidly and accurately triage and treat patients with endometriosis. The project is based on PrecisionLife’s unique insights into the biological mechanisms underpinning this complex chronic disease. It will develop and clinically validate a rapid and non-invasive precision medicine test to evaluate a patient’s risk of endometriosis and the mechanisms underpinning their disease.
🚀 Ready to join a team that’s Revolutionizing Science and Redefining the Workplace?
We’re hiring: Senior Scientist, Protein Sciences
🚀 Ready to join a team that’s Revolutionizing Science and Redefining the Workplace?
We’re hiring: Head of Protein Sciences
At Creasallis, we are committed to revolutionizing science AND the way we work. A passion for making scientific breakthroughs is essential, but so is a desire to co-create an extraordinary workplace and way of being together; and that might be slightly different to what you are used to. At Creasallis, science and culture go hand in hand, and we expect you to play a role in shaping both.
Connecting China’s biotech innovations with the global life science ecosystem through cross-border partnerships.
ChinaBio® Partnering Forum grants the global biopharma community the opportunity to broaden their reach into the China life science market through unmatched cross-border partnerships.
*One Nucleus members receive 15% off the prevailing registration rates. Please contact info@onenucleus.com for the discount code
AMSBIO announces a new range of ready-to-use Human induced Pluripotent Stem Cell (hiPSC) -derived cardiomyocytes, hepatocytes, and neurons. Supplied fully differentiated and available in high-purity formats, these ready-to-use cells help accelerate research by streamlining lab workflows, eliminating the need for in-house differentiation and minimizing preparation time.
This Aon’s Life Sciences webinar offered an insightful discussion on managing risk in Clinical Trials, focusing on insurance, regulatory requirements, and creating operational efficiencies. Attendees learned about the latest trends in risk transfer, hybrid programs, and how technology is streamlining processes to support clinical trial success.
The Webinar also covered areas including:
Primary Stakeholders and exposures, including contractual and service agreements.
EU directive and CTIS database, the transparency rules, and the impact on insurance